Raymond Debbane, Director: Lexicon Pharmaceuticals LXRX Buy · Filed 02/18

Trade details

Type: Insider buy
Amount: $100,682.67
Shares · price: 76,857 sh · $1.31 a share
Held after: 1,520,498 sh
Stock: Lexicon Pharmaceuticals LXRX
Person: Raymond DebbaneDirector
Trade date: 26/02/17
Filed: 26/02/18
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +5.3%

Lexicon Pharmaceuticals trades, last 26 weeks

What else happened in Lexicon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Raymond Debbane's recent trades

Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$2,980
2,000 sh
$2,980
Filed 02/27
Traded 02/25
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$147K
100,000 sh
$147K
Filed 02/25
Traded 02/23
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$148K
100,000 sh
$148K
Filed 02/23
Traded 02/20
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$72K
50,000 sh
$72K
Filed 02/23
Traded 02/19
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$176.5K
133,688 sh
$176.5K
Filed 02/18
Traded 02/18

Raymond Debbane, Director — bought $100.7K of Lexicon Pharmaceuticals LXRX · 76,857 sh @ $1.31 | Whalegun